Syra Health Corp. Class A Common StockSYRANASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR-94.3%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-94.3%/yr
Quarterly compound
Percentile
P50
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 0.02% |
| Q2 2025 | -23.38% |
| Q1 2025 | 6.66% |
| Q4 2024 | 231.20% |
| Q3 2024 | -80.05% |
| Q2 2024 | -0.59% |
| Q1 2024 | 10.48% |
| Q4 2023 | 48.64% |
| Q3 2023 | -1.62% |
| Q2 2023 | -1.10% |
| Q1 2023 | 3.97% |
| Q4 2022 | 16.40% |
| Q3 2022 | 94.34% |
| Q2 2022 | -28.56% |
| Q1 2022 | 0.00% |